RICHARD A. GONZALEZ - 28 Feb 2025 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role: Director
Signature: /s/ T.O. Odutayo, Attorney-in-Fact for Richard A. Gonzalez
Issuer symbol: ABBV
Transactions as of: 28 Feb 2025
Transactions value $: $-35,272,329
Form type: 4
Filing time: 04 Mar 2025, 17:00:22 UTC
Previous filing: 18 Feb 2025
Next filing: 02 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABBV	Common Stock, $0.01 par value	Tax liability	$-15,009,309	-73,209	-13.1%	$205.02	487,557	28 Feb 2025	Direct
transaction	ABBV	Common Stock, $0.01 par value	Sale	$-18,964,471	-92,460	-19%	$205.11	395,097	28 Feb 2025	Direct	F1
transaction	ABBV	Common Stock, $0.01 par value	Sale	$-1,298,549	-6,168	-1.56%	$210.53	388,929	03 Mar 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.09 to $205.45, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.09 to $205.45, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.